Arkolith/Insider Trading/RYTM/Form 4

German Christopher Paul

Corporate Controller & CAORHYTHM PHARMACEUTICALS, INC. (RYTM) · full profile →Form 4 · filed Mar 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$503K
Net Open-Market Flow
-$503K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2026Sell(S)6K$89.56$503K160
Mar 4, 2026Option exercise(M)2K$17.97$27K6K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 4, 2026Option exercise(M)2K—$04K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-024750) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML